Drug Shortage Report for PMSC-ESOMEPRAZOLE DR
| Report ID | 271837 |
| Drug Identification Number | 02528479 |
| Brand name | PMSC-ESOMEPRAZOLE DR |
| Common or Proper name | ESOMEPRAZOLE |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 & 30 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-11-12 |
| Estimated end date | 2026-06-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-13 | French | Compare |
| v1 | 2025-11-13 | English | Compare |
Showing 1 to 2 of 2